Emphasis on catering the healthcare solutions for the rising elderly population is escalating the UK Geriatric Medicine Market

UK geriatric medicine market is projected to grow at a significant CAGR during the forecast period (2020-2026). Geriatric medicine is one of the largest specialties in the UK. It offers a thought-provoking intellectual challenge, which includes illness that presents in unusual ways in older people. As per the European Geriatric Medicine Society, in 2019, the total population of the UK accounted for 66.4 million, in which, the %age of the population above 65 years estimated at 18.3%, whereas the %age of the population above 80 years estimated at 4.9%. Such a huge population base of elderly population, around 7.0 million, needs access to effective healthcare facilities.

Browse the full report description UK Geriatric Medicine Market Size, Share & Trends Analysis Report by Therapeutic (Analgesic, Anticoagulant, Antihypertensive, Antidiabetic, and Others) and by Condition (Cardiovascular Diseases (CVDs), Diabetes, Neurological, Cancer, Respiratory, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/uk-geriatric-medicine-market

Therefore, the market players have a significant presence in UK for the geriatric healthcare solutions and services. Moreover, the Government of UK has a significant focus on improving the healthcare facilities for the elderly population base of the country. The Geriatric Medicine Programme by the Government of UK is further contributing to the development and demand for geriatric medicine in the country. Several academic institutes in the country are developing effective medicines for the geriatric population, offering growth to the geriatric medicine market in UK.

Market Coverage

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?

o Recovery Timeline

o Deviation from pre-COVID-19

o Most affected segment

o Recommendations 

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

UK Geriatric Medicine Market – Segmentation

By Therapeutics

• Analgesic
• Anticoagulant
• Antihypertensive 
• Antidiabetic
• Others (Statins and Antipsychotic)

By Condition

• Cardiovascular Diseases (CVDs)
• Diabetes
• Neurological
• Cancer
• Respiratory
• Others (Arthritis and Osteoporosis)